Mar 1, 2011 . Regeneron Pharmaceuticals, a biopharmaceutical company based in New York,

Nov 22, 2011 . 22, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. . The availability of

Jobs 1 - 10 of 361 . Regeneron has therapeutic candidates in Phase 3 clinical trials for the

RSHC Twitter Feed. Anyone know of any seasonal rentals in SE CT or Southern

Jun 13, 2010 . Regeneron's (REGN) Phase 3 study in gout patients initiating allopurinol therapy

Nov 23, 2011 . Regeneron Pharmaceuticals Inc. announced Tuesday that the Food and Drug

Feb 28, 2011 . Regeneron plans to submit supplemental Biologics License . The primary

Nov 7, 2011 . Adults (N=1315; 18-80 years of age) with gout at risk of a GF due to . Regeneron

Regeneron Pharmaceuticals Inc. News REGN CORRECT: Regeneron Gout

Regeneron has witnessed strong demand for its patented approach to . The

Nov 22, 2011 . But Regeneron started in this business a year or two before I did, and . And the

Feb 28, 2011 . Regeneron Pharmaceuticals of Tarrytown, N.Y., announced positive results from

Consultant/Advisory Boards: Takeda (gout: febuxostat, urate-lowering agent); .

Regeneron has therapeutic candidates in Phase 3 clinical trials for the

Feb 28, 2011 . Regeneron Pharmaceuticals, Inc. announced that its drug Arcalyst has been

Nov 25, 2011 . Regeneron Seeks Label Expansion-Regeneron Pharmaceuticals Inc. is looking

Nov 25, 2011 . From Yahoo! Finance: Regeneron Pharmaceuticals Inc. is looking to expand the

Jun 9, 2010 . Regeneron announced Wednesday that a Phase III study of Arcalyst (rilonacept)

Nov 23, 2011 . Fresh from getting the green light for its blindness drug Eylea, Regeneron

Jun 9, 2010 . Regeneron plans to file by mid-2011 for regulatory approval for ARCALYST in

Jan 9, 2012 . You are here: Home » Medical news » FDA accepts Regeneron's . &#959f gout

Oct 14, 2011 . Regeneron Pharms (NASDAQ: REGN) 's batch had its “buy” rating . is to

Positive Phase 3 clinical studies in gout flare prevention in patients initiating uric

Fresh from getting the green light for its blindness drug Eylea, Regeneron

Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential

Feb 28, 2012 . Dr. Mellis holds a patent, licensed to Regeneron, for the use of interleukin-1

Feb 28, 2011 . FiercePharma is the pharma industry's daily monitor, with a special focus on

Jun 9, 2010 . Regeneron's gout trials are being pursued at the same time the biotech company

52 days ago. FDA will review Regeneron's auto-inflammatory disease drug

Feb 28, 2011 . Regeneron Pharmaceuticals Inc. said its only marketed product, Arcalyst, helped

Nov 22, 2011 . Regeneron Pharmaceuticals Inc. said Tuesday the Food and Drug Administration

Nov 22, 2011 . The Food and Drug Administration accepted for review Regeneron

Gout Bio. GoutBio Gout Bio. Regeneron seeks gout approval for Arcalyst from

Nov 22, 2011 . Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) .

Mar 1, 2011 . Regeneron has reported positive top-line results from a confirmatory trial of its

This may have consequences for both Regeneron (Arcalyst-rilonacept) and

Insight into the race between Novartis' canakinumab and Regeneron's rilonacept

Latest News From "The Pink Sheet" DAILY - Regeneron Submits Arcalyst For

Feb 28, 2011 . Free Daily Biotech Industry Newsletter Get the latest on Biotech & Pharma Deals,

Regeneron owns worldwide rights to ARCALYST®. . A third Phase 3 trial in

Nov 16, 2011 . Regeneron's (REGN) Phase 3 study in gout patients initiating allopurinol therapy

Jun 9, 2010 . Gout drug works as preventive therapy, fails as treatment * Co testing the drug in

Regeneron has therapeutic candidates in Phase 3 clinical trials for the

Nov 29, 2011 . Regeneron Pharmaceuticals Inc. announced that FDA will review its drug

MARKETING MANAGER, ARCALYST FOR TREATMENT OF GOUT JOB, NY |

Feb 21, 2012 . Regeneron Pharms PT Raised to $130.00 by RBC Capital (REGN suto gout,

Sign me in automatically next time FDA acceptance of Arcalyst sBLA puts

Nov 23, 2011 . Regeneron Pharmaceuticals, Inc. has announced that the FDA has . for the

Aug 19, 2010 . Alert icon. We're changing our privacy policy. This stuff matters. Learn more

Mar 2, 2011 . Regeneron Pharmaceuticals has reported that allopurinol therapy Arcalyst (

Sitemap